Skip to nav Skip to content


September 26, 2018


Science Speaks

With a look at obstacles to accessing the newest tuberculosis treatments in the United States, and the ramifications of global TB data, the global Science Speaks blog highlighted needs for accelerated responses against an ancient disease with:

A report on compassionate use of a drug yet to receive approval from the U.S. Food and Drug Administration: Delamanid delay comes home;

Coverage of the World Health Organization launch of its 2018 Global TB report: WHO 2018 global TB report presented as agenda for UN meeting, commitments.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.